This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1t20

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
 +
{{Seed}}
[[Image:1t20.gif|left|200px]]
[[Image:1t20.gif|left|200px]]
Line 9: Line 10:
{{STRUCTURE_1t20| PDB=1t20 | SCENE= }}
{{STRUCTURE_1t20| PDB=1t20 | SCENE= }}
-
'''Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6I'''
+
===Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6I===
-
==Overview==
+
<!--
-
It is well established that even small changes in amino acid side chains of antigenic peptide bound to major histocompatibility complex (MHC) protein may completely abrogate recognition of the peptide-MHC (pMHC) complex by the T cell receptor (TCR). Often, however, several nonconservative substitutions in the peptide antigen are accommodated and do not impair its recognition by TCR. For example, a preponderance of natural sequence variants of the human immunodeficiency virus p17 Gag-derived peptide SLYNTVATL (SL9) are recognized by cytotoxic T lymphocytes, which implies that interactions with SL9 variants are degenerate both with respect to the class I MHC molecule and with respect to TCR. Here we study the molecular basis for this degenerate recognition of SL9 variants. We show that several SL9 variants bind comparably well to soluble HLA-A2 and to a particular soluble TCR and that these variants are active in the cognate cytotoxicity assay. Natural SL9 variation is restricted by its context in the HIV p17 matrix protein. High resolution crystal structures of seven selected SL9 variants bound to HLA-A2 all have remarkably similar peptide conformations and side-chain dispositions outside sites of substitution. This preservation of the peptide conformation despite epitope variations suggests a mechanism for the observed degeneracy in pMHC recognition by TCR and may contribute to the persistence of SL9-mediated immune responses in chronically infected individuals.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16702212}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16702212 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16702212}}
==Disease==
==Disease==
Line 45: Line 49:
[[Category: T-cell receptor]]
[[Category: T-cell receptor]]
[[Category: Tcr]]
[[Category: Tcr]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 09:24:40 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 18:44:00 2008''

Revision as of 15:44, 28 July 2008

Image:1t20.gif

Template:STRUCTURE 1t20

Contents

Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6I

Template:ABSTRACT PUBMED 16702212

Disease

Known disease associated with this structure: Hypoproteinemia, hypercatabolic OMIM:[109700]

About this Structure

1T20 is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes., Martinez-Hackert E, Anikeeva N, Kalams SA, Walker BD, Hendrickson WA, Sykulev Y, J Biol Chem. 2006 Jul 21;281(29):20205-12. Epub 2006 May 15. PMID:16702212

Page seeded by OCA on Mon Jul 28 18:44:00 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1t20"
Personal tools